Researchers at the All-India Institute of Medical Sciences (AIIMS) in Bathinda have made significant progress in stem cell therapy, focusing on treatments for heart diseases. In a promising development, the biochemistry department has successfully conducted preliminary tests on this cutting-edge therapy, providing hope for patients suffering from severe heart conditions.
State-of-the-Art Laboratory Established at AIIMS Bathinda
To facilitate this groundbreaking research, the biochemistry department at AIIMS Bathinda has set up a specialized laboratory. In this facility, researchers are isolating and culturing stem cells derived from the umbilical cords of in-house patients. This marks a crucial step in developing therapies that could eventually be used to treat heart diseases more effectively.
Addressing Heart Disease: A Global Health Crisis
Experts at AIIMS emphasize the critical need for innovative treatments like stem cell therapy, especially given the global prevalence of heart diseases. According to the World Health Organization (WHO), ischemic heart disease and stroke are the leading causes of death worldwide, responsible for approximately 17.4 million deaths annually. These conditions occur when the heart muscle does not receive adequate blood and oxygen, often leading to life-threatening consequences.
The Potential of Stem Cells in Heart Treatment
Stem cells are unique in their ability to multiply and transform into various types of cells, making them highly valuable for cell-based therapies. Unlike traditional treatment options such as surgeries or organ transplants, stem cell therapy offers several advantages. It requires minimal recovery time, poses little risk of disease transmission, and causes fewer side effects. Experts believe that stem cell therapy has the potential to revolutionize how heart diseases are treated by providing a less invasive and more effective solution.
AIIMS Bathinda: A Pioneer in Stem Cell Therapy Research
Dr. Akhilesh Pathak, the Dean of AIIMS Bathinda, highlighted the significance of this development. He mentioned that after AIIMS Delhi, the Bathinda Institute is the only other AIIMS facility in India to have a fully functional and advanced laboratory dedicated to stem cell therapy. According to Dr Pathak, this research could transform regenerative medicine, particularly in treating organ failure and tissue injuries. However, approval from national regulatory agencies will be necessary before these treatments can be widely implemented.
Government Support for Pioneering Research
This ambitious project is supported by the Union government’s Department of Science and Technology through its Core Research Grant (CRG) scheme. The funding underscores the importance of stem cell therapy research and its potential to address critical health challenges.
Standardizing Protocols for Stem Cell Therapy
Dr. Sanjay Kumar, an associate professor in the biochemistry department and the lead researcher on the project, shared updates on the team’s progress. They have successfully standardized the protocols required for stem cell therapy in heart patients. The research has gone beyond merely isolating and culturing stem cells. The team has also achieved pharmacological preconditioning—a clinical technique that uses drugs to protect the heart during the process of reperfusion, where blood flow is restored to previously blocked tissues.
Dr Kumar mentioned that the team is now preparing to submit their protocols for final approval from central authorities. This step will pave the way for tissue transplantation using stem cells in patients suffering from heart diseases. However, it could take up to a year for the technique to be fully validated and for the lab’s procedures to meet good practice standards.
The Complex Science of Stem Cell Medicine
Dr. Rajiv Kumar, medical superintendent at AIIMS Bathinda and head of the cardiothoracic and vascular surgery department, emphasized that stem cell medicine is a complex and evolving science. He stressed the importance of thorough research, technique validation, and evidence-backed results before this treatment can be widely adopted. The researchers at AIIMS Bathinda are diligently working towards these goals, and the medical community is eagerly awaiting the outcomes of this project.
In conclusion, while there is still much work to be done before stem cell therapy for heart diseases becomes a standard treatment, the progress made by AIIMS Bathinda offers hope for the future. With continued research and regulatory approval, stem cell therapy could soon provide a life-saving solution for millions of patients worldwide.
Click here to know more.
